Use of alkaline phosphatase for the detoxification of lps

The present invention provides a use for alkaline phosphatase for the manufacture of a medicament for the prevention or reduction of toxic LPS influx through a mucosal lining of a mammalian body cavity. A source of alkaline phosphatase is administered for the prophylaxis or treatment of LPS mediated...

Full description

Saved in:
Bibliographic Details
Main Authors BRANDS RUDI, POELSTRA KLAAS
Format Patent
LanguageChinese
English
Published 17.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a use for alkaline phosphatase for the manufacture of a medicament for the prevention or reduction of toxic LPS influx through a mucosal lining of a mammalian body cavity. A source of alkaline phosphatase is administered for the prophylaxis or treatment of LPS mediated or exacerbated diseases. The invention also provides compositions comprising a source of alkaline phosphatase for the prevention or reduction of (toxic) LPS influx or passage through mucosal layers.
Bibliography:Application Number: CN200580004103